n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, March 22nd, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Surna, Inc. (SRNA)

PHUB News, Actual Gains, Hot Stock Profits, PennyStockRumors.net, DSR News, PricelessPennyStocks, Value Penny Stocks, Ascending Stocks, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, Marketbeat, CFN Media Group, Cannabis Financial Network News, SmallCapVoice, Greenbackers, OTC Stock Review, and Market Wire Stocks reported on Surna, Inc. (SRNA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. It develops inventive technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. The Company’s mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with a focus on disruptive technology, equipment, as well as related support services. Surna’s goal is to dominate the infrastructure, growing, and support side of the international cannabis industry. Surna is based in Boulder, Colorado.

The Company develops leading-edge technologies and products. The basis of its present revenue stream is on its main product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities. By way of its wholly-owned subsidiary, Hydro Innovations, Surna provides a complete line of commercial and small business indoor agriculture equipment.

A technology business, Surna engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA). Currently, its specialty is commercial indoor cannabis cultivation. Its business model excludes the production or sale of marijuana.

The Company has its signature water-cooled climate control platform. Surna has filed a provisional patent application covering enhancements to its proprietary Climate Control Systems and Methods used in indoor gardens. The patent covers an industrial process that provides electricity, heating, and cooling while using the resulting carbon-dioxide (CO2) produced as a nutrient for the plants.

Surna’s intention is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. The system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

This past November, Surna announced operating and financial results for the three and nine months ended September 30, 2017. Select highlights include Revenue for the three months ended September 30, 2017 of $1,566,000. This represents an increase of $395,000, or 34 percent, versus the three months ended September 30, 2016.

The Company had an Operating Loss of $1,234,000 for the three months ended September 30, 2017 that includes $626,000 of non-cash, equity-based compensation expenses. During the three months ended September 30, 2017, Surna was awarded new sales contracts totaling $2,385,000, bringing the Company’s total new sales contracts awarded for the nine months ended September 30, 2017 to $7,182,000.

Last month, Surna announced that it completed a private placement offering of investment units, at a price of $0.12 per unit, with certain accredited investors. Surna issued 14,734,000 units for aggregate proceeds of $1,768,080.

Chris Bechtel, Surna’s CEO, said, "Surna has recently expanded both its sales and project management teams with key hires, with the objective of ramping organic growth over the next 24 months, and this private placement will help further accelerate that growth plan."

Surna, Inc. (SRNA), closed Thursday's trading session at $0.206, up 6.19%, on 890,848 volume with 206 trades. The average volume for the last 60 days is 1,643,487 and the stock's 52-week low/high is $0.0912/$0.485.

MariMed, Inc. (MRMD)

OTC Markets, Investors Hub, and DailyMarijuanaObserver reported earlier on MariMed, Inc. (MRMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MariMed, Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation and production centers and dispensaries. The Company provides turnkey solutions to cannabis cultivators, producers, and dispensaries. It specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales. MariMed is based in Newton, Massachusetts.

MariMed is focusing exclusively on serving the fast expanding $7 billion legal cannabis industry. MariMed in 2017 announced the purchase of a 137,500 sq. ft. industrial building on 17 acres at 167 John Vertente Blvd., in the New Bedford, Massachusetts industrial park for a purchase price of $6,895,000. MariMed will develop roughly 70,000 sq. ft. into a full service, state-of-the-art medical cannabis cultivation and production facility. This has been leased to ARL Healthcare, Inc. (ARL), a Massachusetts not for profit corporation.

MariMed assisted ARL Healthcare in its successful application to be awarded a Massachusetts Registered Marijuana Dispensary (RMD) License for cultivation, production, and dispensing of medical cannabis. MariMed will assist ARL Healthcare in the development and ongoing management of the cultivation and manufacturing facility.

MariMed is on the vanguard of medical research. The Company is working to create precision dosed products to treat specific conditions. Its team has developed state-of-the-art and regulatory compliant facilities in many states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.

The Company provides a complete range of consulting services in the medical cannabis industry. It uses a systematic approach, from the permit and application process, to on-time operational readiness. As Cannabis experts, it specializes in supporting the development of high quality state-licensed, medical cannabis dispensaries and cultivation facilities.

MariMed’s services include application assistance, real estate and safe access, build-out and continuing consultation, business acceleration solutions, and physician and patient outreach. MariMed Advisors, Inc. has a portfolio of high-quality branded products, product development plans, product packaging, as well as product licensing opportunities.

This past November November, MariMed announced that it acquired the rights to the intellectual property (IP), formulations, recipes, proprietary equipment, and expertise of Betty’s Eddies from Icky Enterprises LLC. This acquisition enables MariMed to further expand its unique, industry-leading Kalm Fusion™ precision dosed medical cannabis-infused product line. Betty’s Eddies is a line of fruit chews handcrafted and naturally sweetened with premier all natural ingredients and non-GMO organic fruits and vegetables.

Recently, MariMed announced that it and its wholly-owned subsidiary Hartwell Realty LLC, on January 25, 2018 received from the Town of Middleborough, Massachusetts, a Special Permit to begin build-out of the 8,000 sq. ft. building at 29 Harding St., Middleborough that MariMed purchased for $1.5 million in August of 2017. MariMed will immediately commence the renovation into a secure, state-of-the-art medical cannabis dispensary expected to serve thousands of state-registered medical cannabis patients.

Last week, MariMed announced that it raised $2.828 million in equity through the sale of its Restricted Common Stock in private placements between October 30, 2017 and January 24, 2018 at prices averaging 15 percent below the market price. These funds were used for the ongoing development of MariMed cannabis facilities in Maryland and Massachusetts.

MariMed, Inc. (MRMD), closed Thursday's trading session at $1.12, up 0.09%, on 77,341 volume with 70 trades. The average volume for the last 60 days is 230,880 and the stock's 52-week low/high is $0.201/$1.48.

Kaya Holdings, Inc. (KAYS)

OTC Markets, Daily Marijuana Observer, Barchart, Equity Clock, Stockhouse, Stockflare, TipRanks, Zacks, The Street, and Microcap Daily reported on Kaya Holdings, Inc. (KAYS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Kaya Holdings, Inc., via subsidiaries, produces, distributes and sells legal premium medical and recreational cannabis products. These include flower, concentrates and oils, and cannabis-infused foods. The Company was previously known as Alternative Fuels America, Inc. It changed its corporate name to Kaya Holdings, Inc. in April of 2015. The Company’s shares trade on the OTCQB. Kaya Holdings is based in Fort Lauderdale, Florida.

The Company is the first fully reporting U.S. public company to own and operate a vertically integrated seed-to-sale legal marijuana enterprise in the U.S. In January of 2014, Kaya Holdings incorporated a subsidiary, Marijuana Holdings Americas, Inc., a Florida corporation (MJAI). Via entities controlled by MJAI, Kaya concentrates on opportunities in the legal recreational and medical marijuana sectors in the U.S.

The Company applied for and was awarded its first license to operate a Medical Marijuana Dispensary in March of 2014. It developed the Kaya Shack™ brand for its retail operations. On July 3, 2014, it opened its first Kaya Shack™ Medical Marijuana Dispensary in Portland, Oregon. In April of 2015, Kaya started its own medical marijuana grow operations for the cultivation and harvesting of legal marijuana.

Kaya Holdings now operates three Kaya Shack™ OLCC ( Oregon Liquor Control Commission) licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon. At present, store number four is under construction.

Furthermore, Kaya recently acquired a 26 acre parcel that it has targeted for development of the Kaya Farms™ Medical and Recreational Marijuana Grow and Manufacturing Complex.

In November 2017, Kaya Holdings announced that it retained the services of the Willard C. Dixon Architect, LLC, architectural design firm of Eugene, Oregon, to design and assist with developing Kaya’s cultivation and manufacturing facilities on its newly acquired 26 acre property in Lebanon, Oregon.

Willard C. Dixon & Associates will assist Kaya with the initial site layout and design of the Kaya Farms™ Marijuana Grow and Manufacturing Facility. This includes securing all necessary permits, creating construction documents, and overseeing construction of cost-effective, energy efficient structures.

In December, Kaya Holdings announced that it completed the processes required to launch its own home delivery service in Portland and Salem, Oregon. It expects to operate four cars initially, with more cars to be added as demand requires and as the Company expands into other cities in Oregon.

Kaya Holdings is planning execution of its stated business goals in accordance with current understanding of State and Local Laws and Federal Enforcement Policies and Priorities as it relates to Marijuana (as outlined in the Justice Department's Cole Memo dated August 29, 2013). The Company plans to proceed cautiously with respect to legal and compliance issues.

Kaya Holdings, Inc. (KAYS), closed Thursday's trading session at $0.1399, up 0.36%, on 155,759 volume with 41 trades. The average volume for the last 60 days is 522,908 and the stock's 52-week low/high is $0.10/$0.31.

Fiore Gold Ltd. (FIOGF)

Stock Orange, Investors Hangout, Barchart, Stockhouse, Energy and Gold, Stockwatch, and WatchDog Stocks reported on Fiore Gold Ltd. (FIOGF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Fiore Gold Ltd. is a new America’s-focused gold producer and explorer. The Company has the producing Pan Mine in the State of Nevada. Moreover, it has a group of exploration projects in Nevada, Washington and Chile. Fiore Gold’s objective is to build a new mid-tier mining company in the world’s top mining jurisdictions. The Company’s initial goal is on becoming a 150,000-ounce/year gold producer. Fiore Gold has offices in Toronto, Ontario; Vancouver, British Columbia; and Englewood, Colorado.

Concerning South American Properties, Fiore Gold has its Pampas El Peñon properties; the Cerro Tostado project; and the Rio Loa property. The Pampas El Peñon property comprises 13 mining claims totaling 3,400 hectares. It is located about 130 kilometers southeast of Antofagasta, Chile.

Regarding North American Projects, the Company’s assets include the above-mentioned, producing Pan Mine near Eureka, Nevada. Assets also include the nearby Gold Rock exploration project. Also, the Company controls the Golden Eagle advanced exploration project in Washington State.

The Pan Mine is a Carlin-style, sediment-hosted, gold-only deposit. It consists of three main zones of mineralization that has currently been traced for greater than 6,000 feet along the north-south Branham Fault. The 2017 Pan Mine Feasibility Study (FS) defines Proven and Probable reserves of 318,000 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton).

The Cerro Tostado (South America) project consists of five concessions totaling around 1,500 ha situated in Region II approximately 125 km southeast of Antofagasta. Cerro Tostado is positioned just south of the main and Fortuna zones of Yamana Gold's flagship El Peñon Mine.

The Rio Loa property is situated in the northern part of the prolific Maricunga gold belt. The 1,000 Ha Rio Loa property is located approximately 25 km south of Salares Norte. This property is accessible year-round by road.

In November 2017, Fiore Gold announced the results of the Phase I diamond and reverse-circulation (RC) drilling program at its Cerro Tostado project in Chile, following up on high-grade epithermal silver mineralization earlier intersected by three of 18 holes drilled between 2010 and 2012 by Sociedad Quimica Y Minera de Chile SA (SQM).

Phase 1 of the Cerro Tostado program included four oriented-core diamond drill holes targeting the earlier-identified high-grade silver mineralization. In addition, the program included two new targets identified from mapping, surface sampling, and trenching.

Recently, Fiore Gold announced the start of exploration drilling at its Pan Mine in Nevada, as part of a longer-term program intended to expand the resource and reserve base at Pan. This present program will consist of roughly 11,500 feet of reverse circulation drilling and be centered in the vicinity of the North Pit that hosts most of the silica-rich rocky ore at Pan.

Moreover, drilling will take place in the Central area of the deposit to expand existing resources there and test new targets. Mining is now taking place in the rocky North Pan Zone and the clayey South Pan Zone, with the run-of-mine ores blended on the leach pad.

In late February, Fiore Gold provided results from the first six holes of its 2018 drill program at its Pan Mine in Nevada. Highlights from the first six holes include Hole PND18-06 returning 79.2 meters of 0.55 g/t (260 ft of 0.016 oz/t gold); Hole PND18-03 intercepted 82.3 m of 0.45 g/t gold (270 ft of 0.013 oz/t gold); and Hole PND18-01 drilled 65.5 m of 0.38 g/t gold (215 ft of 0.011 oz/t).

Fiore Gold Ltd. (FIOGF), closed Thursday's trading session at $0.52, even for the day, on 45,343 volume with 37 trades. The average volume for the last 60 days is 179,585 and the stock's 52-week low/high is $0.4648/$0.9537.

Humanigen, Inc. (HGEN)

TradingView, Investopedia, InvestorsHub, OTC Markets, AmigoBulls, Barchart, Investors Hangout, and Financial Times reported on Humanigen, Inc. (HGEN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Humanigen, Inc. centers on advancing medicines for patients with neglected and rare diseases via innovative, accelerated business models. Lead compounds in the Company’s portfolio include the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab. Derived from its Humaneered® platform, lenzilumab and ifabotuzumab are lead compounds in the portfolio of monoclonal antibodies with first-in-class mechanisms. Humanigen is headquartered in Brisbane, California.

The Company pursues innovative science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments. Lenzilumab has potential for treatment of various rare diseases. These include hematologic cancers such as chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).

Lenzilumab is a Humaneered® recombinant monoclonal antibody. It neutralizes soluble granulocyte-macrophage colony-stimulating factor (GM-CSF), which is a critical cytokine that drives the growth of certain hematologic malignancies.

The other key asset in the Company’s monoclonal antibody portfolio, ifabotuzumab, has been dosed in the first patient in an investigator-sponsored Phase 0/1 radio-labeled imaging trial in glioblastoma multiforme (GBM). GBM is a particularly aggressive and deadly brain cancer.

Ifabotuzumab is a first-in-class, monoclonal antibody. It targets the EphA3 receptor tyrosine kinase created utilizing Humanigen's proprietary Humaneered® technology.

Last week, Humanigen announced that it completed patient enrollment in the continuing Phase 1 trial of lenzilumab in patients with previously treated chronic myelomonocytic leukemia (CMML). The design of the Phase 1, multi-center, open-label, dose-escalation trial is to evaluate the maximum tolerated dose, safety and tolerability of single-agent lenzilumab in 12 patients with CMML who are relapsed, refractory to, or intolerant to standard-of-care treatments. In addition, the trial will provide more data on pharmacokinetics and pharmacodynamics.

Mr. Cameron Durrant, M.D., Chairman and Chief Executive Officer of Humanigen, said, “Full enrollment of the CMML trial shows our unflinching commitment to execution on the important work to progress our assets, strengthen our company and to drive value for patients and all our stakeholders. We look forward to more milestones quickly ahead as we compile an interim report on the safety of lenzilumab in CMML and we initiate a planned Phase 1b/2 study to assess lenzilumab’s potential to prevent and/or reduce neurotoxicity related to CAR-T cancer therapy.”

Humanigen, Inc. (HGEN), closed Thursday's trading session at $0.68, up 10.57%, on 6,573 volume with 6 trades. The average volume for the last 60 days is 14,445 and the stock's 52-week low/high is $0.125/$2.98.

Abattis Bioceuticals Corp. (ATTBF)

Stockgoodies, Cannabis Financial Network News, Greenbackers, Promotion Stock Secrets, InvestorIntel, CFN Media Group, Goldman Small Cap Research, PennyStocks24, and Information Solutions Group reported earlier on Abattis Bioceuticals Corp. (ATTBF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Abattis Bioceuticals Corp. is a life sciences and biotechnology company listed on the OTC Markets Group’s OTCQB. The Company aggregates, integrates, as well as invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. It has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. Essentially, Abattis has positioned itself to be a foremost service provider in the cannabis industry.

Abattis Bioceuticals has its corporate headquarters in Vancouver, British Columbia. It has an operations office in Langley, British Columbia. The Company’s brands include Northern Vine Labs™ and Vergence Naturals™.

In addition, Abattis is working to acquire exclusive intellectual property (IP) rights to agricultural technologies to be utilized in extraction and processing of botanical ingredients and compounds.Via its operations and wholly-owned subsidiaries, the Company has a wide spectrum of capabilities. These include cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

The Company has a Federally Licensed Testing Lab. Its Northern Vine Labs holds a controlled substance dealers license from Health Canada. In addition, Northern Vine Labs' product formulation specialists can create and consult on custom developed products. Furthermore, Abattis Bioceuticals has exclusive distribution rights to sell and service an industrial scale and cost effective extraction technology.

In early March, Abattis Bioceuticals announced that, further to the Company’s news release dated February 27, 2018, it completed its acquisition of a 90 percent ownership interest in Gabriola Green Farms, Inc. Gabriola is a British Columbia (BC) company.

Gabriola has applied for a license to produce (LP) under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of British Columbia. At present, Gabriola has plans for a roughly 26,000 square-foot production facility to produce medical-grade marijuana situated on 18 acres in the agricultural land reserve on Gabriola Island, BC.

Last week, Abattis Bioceuticals announced that it entered into a Non-Binding Letter of Intent (LOI) with Canadian Artesian Ice Ltd. This is to provide Canadian Artesian with, among other things, THC- and pesticide-free cannabidiol (CBD) isolate, research and development (R&D) services, nanoencapsulation and nanoemulsification services, analytical and regulatory services and access to Abattis Bioceuticals’ distribution and marketing channels to support the development, scalability and commercialization of a CBD-infused water for Canadian Artesian. Canadian Artesian is a bottler of Premium artesian 7.8 pH mineral water.

This week, Abattis Bioceuticals announced that it signed an LOI with dicentra, Inc. to create a regulatory services partnership under which dicentra will provide a family of services to support Abattis Bioceuticals’ present and future regulatory and compliance requirements. With this LOI, Abattis and dicentra have agreed to negotiate in good faith the terms of a definitive agreement regarding the Partnership. The agreement will include representations, warranties and covenants usual for an arrangement of like nature to the Partnership and will take over from the LOI.

Abattis Bioceuticals Corp. (ATTBF), closed Thursday's trading session at $0.211, down 11.70%, on 1,479,219 volume with 595 trades. The average volume for the last 60 days is 1,683,296 and the stock's 52-week low/high is $0.0471/$0.7444.

GEX Management, Inc. (GXXM)

OTC Markets and MarketWatch reported on GEX Management, Inc. (GXXM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GEX Management, Inc. is a licensed Professional Employer Organization (PEO) and a Professional Services Company. It provides complete back office services to its clients in an assortment of industries. As a PEO, GEX provides Human Resources (HR) services for its clients. This includes the payment of wages and taxes, and assisting with state and federal rules and regulation compliance. OTCQB-listed, GEX Management has its corporate office in Dallas, Texas.

The Company’s services include HR, Payroll, Risk & Compliance Management, Digital Marketing, IT (Information Technology), Executive consulting, as well as Accounting/Bookkeeping. The Company uses specially designed technology and a team of professionally trained staff to give clients support and accountability.

GEX also provides basic bookkeeping services to its clients. This includes Accounts Payable (A/P); Accounts Receivable (A/R); Accounting Manual and Policy Review; Full Service Accounting Services (Bookkeeping); Paperless Workflow System Implementation; and Document Retention. The Company’s staff can perform cash-based or accrual accounting.

In 2017, GEX Management announced the addition of Mr. Andrew Percy, Member of Parliament in the House of Commons of the United Kingdom (UK), and Mr. Jason Bailey, Investment and Business Asset Manager of a private family office, to the GEX Advisory Board team.

Mr. Percy is a three term Member of Parliament in the House of Commons in the UK. Mr. Bailey’s current responsibilities include managing a portfolio of public and private investments, supervision of real-estate investment developments, and day-to-day business logistics.

GEX Management also announced in late 2017 the opening of its Northwest Arkansas regional office. This regional office is next to the Northwest Arkansas Mall. It serves the cities of Springdale, Bentonville, Fayetteville, Rogers and their surrounding communities. The Company’s new office serves as a local base of operation to work with businesses that are fuelling the current economic growth of Northwest Arkansas.

Last week, GEX Management announced that in a specially-held meeting, and in accordance with its governing documents, the Board of Directors voted to separate the roles of Chief Executive Officer (CEO) and President. Chelsea Christopherson was elected and now serves as President and Chief Operating Officer (COO) of GEX Management. The decision enables Carl Dorvil to more exclusively devote his attention to his role as CEO.

GEX Management, Inc. (GXXM), closed Thursday's trading session at $3.44, down 0.29%, on 500 volume with 2 trades. The average volume for the last 60 days is 235 and the stock's 52-week low/high is $1.10/$10.83.

Omnitek Engineering Corp. (OMTK)

Marketbeat, FeedBlitz, OTCPicks, and Penny Stock Rumble reported previously on Omnitek Engineering Corp. (OMTK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines that use Omnitek’s technology. These provide its global customers with inventive alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering is headquartered in Vista, California.

The Company’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established Omnitek Engineering as a leader in the industry.

Omnitek’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. Omnitek Engineering’s commitment is to be at the forefront of technology. Furthermore, the Company’s commitment is to develop innovative solutions that redefine the future of low emissions, energy independence, and transportation.

The Company has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, initially for the widely-used Mercedes OM904 and OM906 engines. LKQ is a foremost provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Omnitek Engineering has received worldwide certification for its patented fuel rail technology. This is based on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.

Omnitek will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories (Fullerton, California). The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.

Omnitek will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through using its patented diesel-to-natural gas engine conversion technology. Olson-Ecologic Engine Testing Laboratories will serve as project manager.

This month, Omnitek Engineering announced that it received a contract to develop a heavy-duty 12-liter propane engine for Class 8 trucks and certify the engine to EURO 6 emissions standards. The 12-liter 360 hp propane (LPG) engine complements Omnitek’s current development of a 13-liter 450 hp heavy-duty natural gas engine for Class 8 truck applications to meet EURO 6 emissions.

Omnitek Engineering Corp. (OMTK), closed Thursday's trading session at $0.07, up 10.76%, on 1,000 volume with 1 trade. The average volume for the last 60 days is 13,478 and the stock's 52-week low/high is $0.054/$0.20.

NuZee, Inc. (NUZE)

NetworkNewsWire, Zacks, OTC Markets, MarketWatch, Barchart, InvestorsHub, Capital Cube, Business Insider, and Stockopedia reported on NuZee, Inc. (NUZE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

NuZee, Inc. concentrates on building beverage brands that offer functional and nutritional benefits. The Company (d/b/a Coffee Blenders®) is the pioneer in functional coffee. It offers gourmet specialty grade coffee in convenient single serve cups using only natural ingredients with clinically supported nutraceuticals. Established in 2011, NuZee has its corporate headquarters in Vista, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

NuZee manufactures and sells its Drip Cup line of single serve, pour-over functional coffees. These include Lean Cup® (for weight loss), Think Cup® (for cognitive performance), Relax Cup® (for stress reduction), Active Cup® (for a pre-workout boost of energy), Nude Cup® (100 percent Arabica coffee with no function), and Matcha Cup tea.

The Company’s customers include B2B (Business-to-Business) multi-store retail chains and wholesale distributors, which deliver to chain and independent stores. In addition, NuZee sells its products to office and home delivery services that deliver coffee and water to homes and businesses locally.

In November 2017, NuZee announced that it would launch its ready-to-drink (RTD) gourmet, functional, cold brew coffee line. This product will at first be available at independent retailers and convenience stores across Southern California. A national roll-out is contemplated to begin over the next 6-12 months (from November 2017).

This past December, NuZee announced that it has undertaken the expansion of its existing production facility in Vista, California. This is to accommodate the growth of the Company’s Drip Cup line of functional gourmet coffee sold under the Coffee Blenders® brand name. NuZee will add two new Drip Cup co-packing machines and upgrade process automation as part of this expansion.

Masa Higashida, Chief Executive Officer of NuZee, said in December 2017, "This expansion reflects our success to date, as well as our confidence for continuing growth in 2018 and beyond. As announced earlier this month, NuZee has been granted the exclusive North American rights to utilize NASA Corporation's proprietary Drip cup packing machinery brand FUSO in the manufacturing of our Coffee Blenders line of Drip Cup coffee products. This technology, which manufactures the majority of the 2.3 billion Drip Cups used each year in Japan, provides us with a significant competitive advantage."

NuZee, Inc. (NUZE), closed Thursday's trading session at $1.19, up 48.75%, on 100 volume with 1 trade. The average volume for the last 60 days is 255 and the stock's 52-week low/high is $0.25/$0.95.

Cartesian, Inc. (CRTN)

The Street, Stock Twits, InvestorsHub, and StockNewsUnion reported on Cartesian, Inc. (CRTN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Established in 1990, Cartesian, Inc. is a top provider of consulting services and managed solutions to the global telecommunications, media, and technology industries. The Company provides strategic advice, management consulting, and also managed solutions to clients internationally. Cartesian lists on the OTC Markets Group’s OTCQB. The Company has offices in Boston, New York, Philadelphia, Washington, Paris and London. Cartesian is headquartered in Overland Park, Kansas.

The Company previously went by the name The Management Network Group, Inc. It changed its name to Cartesian, Inc. in June of 2014.

With its technical and commercial knowledge, the Company assists its clients across their core business operations. Cartesian helps with customer acquisition and retention; network transformation, business strategy and planning, product management, and investment advisory. In addition, it helps with business operations and change, assurance and cost optimization, video services delivery and security, and regulatory support and expert witnesses.

Cartesian’s clients include Service Providers and Network Operators; Technology Firms; and Digital Media Producers and Distributors. Clients also include Government and Regulatory Authorities; Industry Associations, and Private Equity Firms.

Cartesian announced in 2017 that Mr. Donald J. Tringali was appointed as Executive Chairman of the Company’s Board of Directors. Mr. Tringali is performing all duties typically performed by a Board Chairman. He has served as a director of Cartesian since April of 2016.

Mr. Tringali is leading the Board of Director’s efforts in working closely with management to formulate and implement strategic and operational initiatives to enhance Cartesian’s performance.

Today, Cartesian announced that its Strategic Review Committee and Board of Directors unanimously approved the Company entering into an Agreement and Plan of Merger to be acquired by an affiliate of Blackstreet Capital Holdings, which will result in Cartesian becoming a privately held company upon completion of the merger. Blackstreet Capital Holdings is a Chevy Chase, Maryland-based private, diversified holding company.

The first step in the transaction is a tender offer under which an affiliate of Blackstreet Capital Holdings, the Acquiror, will offer to acquire all outstanding shares of Cartesian for $0.40 per share, a premium of 137 percent over the closing price of the Company’s common stock on March 21, 2018.

Cartesian, Inc. (CRTN), closed Thursday's trading session at $0.382, up 126.17%, on 3,678,154 volume with 332 trades. The average volume for the last 60 days is 18,493 and the stock's 52-week low/high is $0.05/$1.19.

graphic

The QualityStocks
Company Corner

graphic
graphic

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $0.87, up 0.58%, on 143,033 volume with 75 trades. The stock’s average daily volume over the past 60 days is 308,938 and its 52-week low/high is $0.543/$1.5835.

MGX Minerals Inc. (CSE: XMG / FKT: 1MG / OTCQB: MGXMF) is pleased to announce it has retained the services of Capstone Headwaters LLC (“CSHW”) to provide investment banking and financial advisory services. Advancement of the Company’s lithium, magnesium and energy assets will remain in focus.

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals Selects Capstone Headwaters for Merger and Acquisition Advisory; Focus on Lithium, Magnesium and Energy Technology

MGX Minerals Recognized as Double Finalist for S&P Global Platts Metals Awards

MGX Minerals Engages Hatch Ltd. for Magnesium Metal Study at Driftwood Creek, British Columbia

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG). Today, Medical Cannabis Payment Solutions closed trading at $0.032, even for the day, on 663,231 volume with 29 trades. The stock’s average daily volume over the past 60 days is 606,895, and its 52-week low/high is $0.0161/$0.12.

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) has developed its Green system to fight the cash-only problem that has been obstructing the cannabis industry. To view the full article, visit: http://cnw.fm/2BexL.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company's state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company's unique "StateSourced" proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven't been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin's cryptocurrency ($Weed) with Medical Cannabis Payment Solutions' StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

"We've completed our transition from development stage to revenue stage," says Roberts. "We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases."

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry. Disclaimer

Medical Cannabis Payment Solutions Company Blog

Medical Cannabis Payment Solutions News:

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Combats Cash-only Market Woes with the Green System

Medical Cannabis Payment Solutions (REFG) Now Available To Entire Legal Cannabis Industry

Medical Cannabis Payment Solutions Fully Launches Payment System, Establishments May Now Enroll

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.1097, off by 0.27%, on 125,187 volume with 29 trades. The stock’s average daily volume over the past 60 days is 368,166, and its 52-week low/high is $0.0045/$0.52.

Epazz, Inc. (OTC: EPAZ), a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that its Patent Pending Blockchain Smart Legal will generate new sources of revenue. Epazz will offer Cordtell on a monthly subscription fee starting at $299 per month.

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz’s Patent Pending Blockchain Smart Legal Contracts (Cordtell) will Generate New Sources of Revenue with Dispute Resolution

NetworkNewsBreaks – Epazz, Inc. (EPAZ) Advances Toward Million User Goal for ZenaPay Cryptocurrency Wallet

Epazz Social Media Blockchain Decentralized Platform to Be Released on June 30

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.861, off by 2.00%, on 264,842 volume with 236 trades. The stock’s average daily volume over the past 60 days is 294,117, and its 52-week low/high is $0.3148/$1.3041.

First Cobalt Corp. (TSXV: FCC) (ASX: FCC) (OTCQB: FTSSF) today announces the filing of an independent NI 43-101 technical report on its Greater Cobalt Project located near Cobalt, Ontario. This report encompasses all the Cobalt Camp properties resulting from the 2017 merger with Cobalt One and CobalTech.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

First Cobalt Files 43-101 Technical Report on Cobalt Camp Properties

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Commences Metallurgical Study at Cobalt Camp

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Targets Historically-producing Mines in Cobalt North

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.369, off by 1.36%, on 1,461,876 volume with 409 trades. The stock’s average daily volume over the past 60 days is 14,482,269, and its 52-week low/high is $0.0006/$0.957.

Cannabidiol-focused holding company PotNetwork Holding (OTC: POTN) this morning said that its wholly-owned subsidiary, Diamond CBD Inc., displayed its innovative animal health and wellness products at the Global Pet Expo held in Orlando, Florida on March 21, 2018. To view the full press release, visit: http://cnw.fm/Kc91G.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Exhibits Natural Organic CBD Oil at the Global Pet Expo

PotNetwork Holding Inc. Leadership Appears on The Mick Bazsuly Show, Projects 60-70% Gains in Revenues for 2018

PotNetwork Holding, Inc. Senior Advisor Bruce BarrenBarren to appear on National Radio and Webcast Today, Tuesday March 20th, 2018

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.13, off by 4.24%, on 246,152 volume with 286 trades. The stock’s average daily volume over the past 60 days is 340,274 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), a drug delivery platform innovator, announces it has received a new Notice of Allowance from the United States Patent and Trademark Office ("USPTO") providing for "composition of matter" claims that protect the specific combination of substances which enable improved taste and bioabsorption properties of its DehydraTECH™ technology for the delivery of cannabinoids.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for "Composition of Matter" Cannabinoid Delivery

Lexaria Files New Patent Application for Enhanced Transdermal Delivery System

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Generate up to 80% of Revenues from Technology Licensing

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0161, off by 5.85%, on 5,835,547 volume with 130 trades. The stock’s average daily volume over the past 60 days is 11,233,647, and its 52-week low/high is $0.0141/$0.16.

Payment solutions company Global Payout, Inc. (OTC: GOHE), through majority-owned subsidiary MoneyTrac Technology, Inc. (“MTRAC”), this morning announced its attendance at the Cali-Baja Israel Mexico Innovation Expo in Tijuana on March 20-21. To view the full press release, visit: http://nnw.fm/4c0GZ.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Attends Cali-Baja Israel Mexico Innovation Expo

Branding the Future of Cannabis: MoneyTrac Engages NisonCo in Public Relations Agreement

Disrupting Business: Blockchain Technology Offers Solutions across the Board

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.525, off by 6.25%, on 76,832 volume with 46 trades. The stock’s average daily volume over the past 60 days is 90,519 and its 52-week low/high is $0.40/$1.58.

Investors are excited to hear what ChineseInvestors.com, Inc. (OTCQB: CIIX) said about its big moves into the blockchain space on Investor Town Hall Show. ChineseInvestors.com, the premier financial information website for Chinese-speaking investors, commissioned additional revenue streams with ASIC mining machines that generate both Bitcoin and Litecoin.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News

Chineseinvestors.com, Inc. (CIIX) Talks Cryptocurrencies, Mining and More on Investor Town Hall Show

ChineseInvestors.com, Inc. Explores Investments Into Cryptocurrency Mining Through Testing of ASIC (Application Specific Integrated Circuit) Machines With Plans to Expand Its Mining Operations in the Near Future

ChineseInvestors.com, Inc. (CIIX) CEO Discusses the Company’s Future on MoneyTV

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P)

The QualityStocks Daily Newsletter would like to spotlight Liberty Leaf Holdings Ltd. (LIBFF). Today, Liberty Leaf Holdings Ltd. closed trading at $0.3483, off by 7.91%, on 9,808 volume with 13 trades. The stock’s average daily volume over the past 60 days is 133,438, and its 52-week low/high is $0.0091/$0.8074.

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) offers investors a unique option for diversified exposure across the entire legal cannabis market. To view the full article, visit: http://cnw.fm/k9G1L.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF), is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

  • North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
  • Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

  • ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
  • Blox Labs Inc. – A boutique technology company focused on creating best-in-class smartphone apps and software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years. Disclaimer

Liberty Leaf Holdings Ltd. Company Blog

Liberty Leaf Holdings Ltd. News:

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Leverages Opportunity in Cannabis Industry through Strategic, Diversified Investments

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Readies Niche Products for Legal Cannabis Industry

NetworkNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) Complete Preliminary Input and Analysis in Phase One Development of cannaBLOX

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF). Today, Choom Holdings Inc. closed trading at $0.677, off by 12.42%, on 314,097 volume with 148 trades. The stock’s average daily volume over the past 60 days is 85,604, and its 52-week low/high is $0.125/$0.8612.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Choom Holdings Inc. (CSE:CHOO) (OTCQB:CHOOF), a client of CNW focused on channeling the spirit of Hawaii in the Okanagan and building culture around its high-grade handcrafted cannabis brand. To view the full publication, titled “Big and Small Companies Partner Up to Provide Canada’s Cannabis,” visit: http://nnw.fm/n8m8J.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™. Disclaimer

Choom Holdings Inc. Company Blog

Choom Holdings Inc. News:

NetworkNewsWire Announces Publication on Savvy Partnerships and Investment Ahead of Canada’s Cannabis Boom

NetworkNewsWire Announces Publication on Innovators Aiming High in Canadian Cannabis Industry

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Signs Deal to Open Multiple Choom™ Branded Retail Dispensaries

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(CRTN) +126.17%

2.

StockMarketWatch
(OMEX) +118.42%

3.

Trader Power News
(NAUH) +44.86%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251